Product CAS No

82956-11-4

Product Description

Nafamostat mesylate, a synthetic serine protease inhibitor, is a short-acting anticoagulant and is also used for the treatment of pancreatitis. It also has some potential antiviral and anti-cancer properties.

Therapeutic Action

Nafamostat Mesylate is the mesylate salt form of nafamostat, a broad-spectrum, synthetic serine protease inhibitor, with anticoagulant, anti-inflammatory, mucus clearing, and potential antiviral activities. Nafamostat inhibits the activities of a variety of proteases, including thrombin, plasmin, kallikrein, trypsin, and Cl esterase in the complement system.